This event will premiere on this page at 10:00 a.m. EDT, Friday, April 15. Register for the event here
Join Hudson Institute Senior Fellow Urška Petrovčič and expert panelists David Kappos, Erika Lietzan, and Senior Fellow Adam Mossoff for a discussion on the role of drug patents as a driver of innovation in healthcare and the importance of evidence-based policymaking in patent law.
Congress and federal agencies have been holding hearings, issuing reports, and considering various policy measures on whether drug patents raise prices in healthcare. These legislative and policy efforts have been driven by reports published by I-MAK of massively high numbers of patents on specific drugs. Yet as a recent Hudson Institute policy memo by Adam Mossoff explains, I-MAK’s patent numbers are unreliable and its private database is unverifiable. Please join our expert panel for a discussion on the policy debate over drug patents and the importance of evidence-based policymaking by Congress and agencies.
Join Hudson for an expert panel on how reliable and effective patent rights are the key to the America First agenda: growing the US innovation economy, creating jobs, and responding to challenges from global competitors like China.
Join Hudson for a panel that will examine some of the tools that could help revitalize US investment in the region, including development finance, political risk insurance, and economic innovation zones.
Join Hudson Senior Fellow Bryan Clark for a discussion of the opportunities and challenges in establishing a new weapons design and development approach with leaders from the US Air Force, Defense Innovation Unit, and US defense industry.
Join Adam Mossoff for a conversation with the author about why IP protections are essential for fostering human flourishing, how the American system has been degraded, and steps policymakers can take to restore the system that has benefited the US and the world.
